Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03106779
Title Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | CAN | AUS

Facility Status City State Zip Country Details
University of Chicago Hospital Chicago Illinois 60637 United States Details
Indiana Blood and Marrow Institute Regulatory - 2 Beech Grove Indiana 46107 United States Details
Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21205 United States Details
Dana Farber Cancer Center Boston Massachusetts 02215 United States Details
University of Michigan Clinical Trials Office Main Site Ann Arbor Michigan 48109 United States Details
Roswell Park Cancer Institute . Buffalo New York 14263 United States Details
Weill Cornell Medicine NY-Presb New York New York 10021 United States Details
Memorial Sloan Kettering Cancer Ctr . New York New York 10065 United States Details
Uni of TX MD Anderson Cancer Cntr Houston Texas 77030 United States Details
Utah Huntsman Cancer Center Salt Lake City Utah 84112 United States Details
Novartis Investigative Site Caba Buenos Aires C1221ADH Argentina Details
Novartis Investigative Site Capital Federal C1114AAN Argentina Details
Novartis Investigative Site Cordoba X5016KEH Argentina Details
Novartis Investigative Site Adelaide South Australia 5000 Australia Details
Novartis Investigative Site Melbourne Victoria 3000 Australia Details
Novartis Investigative Site Murdoch Western Australia 6150 Australia Details
Novartis Investigative Site Rio de Janeiro RJ 20.211-030 Brazil Details
Novartis Investigative Site Sao Paulo SP 05403 000 Brazil Details
Novartis Investigative Site Sao Paulo SP 08270-070 Brazil Details
Novartis Investigative Site Porto Alegre 90035-003 Brazil Details
Novartis Investigative Site Plovdiv 4002 Bulgaria Details
Novartis Investigative Site Varna 9000 Bulgaria Details
Novartis Investigative Site Toronto Ontario M5G 2M9 Canada Details
Novartis Investigative Site Ostrava Poruba 708 52 Czechia Details
Novartis Investigative Site Brno Bohunice 625 00 Czechia Details
Novartis Investigative Site Bordeaux 33076 France Details
Novartis Investigative Site Lyon 69373 France Details
Novartis Investigative Site Marseille 13273 France Details
Novartis Investigative Site Paris 10 75475 France Details
Novartis Investigative Site Vandoeuvre les Nancy 54511 France Details
Novartis Investigative Site Mannheim Baden Wuerttemberg 68305 Germany Details
Novartis Investigative Site Berlin 13353 Germany Details
Novartis Investigative Site Duesseldorf 40225 Germany Details
Novartis Investigative Site Frankfurt 60590 Germany Details
Novartis Investigative Site Heidelberg 69120 Germany Details
Novartis Investigative Site Jena 07740 Germany Details
Novartis Investigative Site Kiel 24116 Germany Details
Novartis Investigative Site Budapest 1097 Hungary Details
Novartis Investigative Site Debrecen 4032 Hungary Details
Novartis Investigative Site Jerusalem 9112001 Israel Details
Novartis Investigative Site Zrifin 70300 Israel Details
Novartis Investigative Site Bari BA 70124 Italy Details
Novartis Investigative Site Milano MI 20122 Italy Details
Novartis Investigative Site Napoli 80132 Italy Details
Novartis Investigative Site Nagoya Aichi 453-8511 Japan Details
Novartis Investigative Site Toyoake city Aichi 470 1192 Japan Details
Novartis Investigative Site Kashiwa Chiba 277 8577 Japan Details
Novartis Investigative Site Kobe-shi Hyogo 650-0017 Japan Details
Novartis Investigative Site Osaka Sayama Osaka 589 8511 Japan Details
Novartis Investigative Site Suita Osaka 565 0871 Japan Details
Novartis Investigative Site Bunkyo ku Tokyo 113-8677 Japan Details
Novartis Investigative Site Chuo-city Yamanashi 409-3898 Japan Details
Novartis Investigative Site Akita 010-8543 Japan Details
Novartis Investigative Site Aomori 030 8553 Japan Details
Novartis Investigative Site Uijeongbu si Gyeonggi Do 11759 Korea, Republic of Details
Novartis Investigative Site Seoul Seocho Gu 06591 Korea, Republic of Details
Novartis Investigative Site Busan 49201 Korea, Republic of Details
Novartis Investigative Site Jeollanam 519763 Korea, Republic of Details
Novartis Investigative Site Ashrafieh 166830 Lebanon Details
Novartis Investigative Site Beirut 1107 2020 Lebanon Details
Novartis Investigative Site Monterrey Nuevo Leon 64460 Mexico Details
Novartis Investigative Site Amsterdam 1081 HV Netherlands Details
Novartis Investigative Site Dordrecht 3318AT Netherlands Details
Novartis Investigative Site Cluj-Napoca 400124 Romania Details
Novartis Investigative Site Timisoara 300079 Romania Details
Novartis Investigative Site Moscow 125167 Russian Federation Details
Novartis Investigative Site Moscow 125284 Russian Federation Details
Novartis Investigative Site Saint Petersburg 191024 Russian Federation Details
Novartis Investigative Site Saint Petersburg 197341 Russian Federation Details
Novartis Investigative Site Riyadh 11211 Saudi Arabia Details
Novartis Investigative Site Belgrade 11000 Serbia Details
Novartis Investigative Site Novi Sad 400107 Serbia Details
Novartis Investigative Site Toledo Castilla La Mancha 45071 Spain Details
Novartis Investigative Site Barcelona Catalunya 08036 Spain Details
Novartis Investigative Site Hospitalet de LLobregat Catalunya 08907 Spain Details
Novartis Investigative Site Bilbao Pais Vasco 48013 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Zürich 8091 Switzerland Details
Novartis Investigative Site Istanbul TUR 34098 Turkey Details
Novartis Investigative Site Adana 01330 Turkey Details
Novartis Investigative Site Istanbul 34093 Turkey Details
Novartis Investigative Site Izmir 35040 Turkey Details
Novartis Investigative Site Samsun 55139 Turkey Details
Novartis Investigative Site Wirral Merseyside CH63 4JY United Kingdom Details
Novartis Investigative Site Cardiff CF4 4XN United Kingdom Details
Novartis Investigative Site Glasgow G12 0YN United Kingdom Details
Novartis Investigative Site London W12 0HS United Kingdom Details
Novartis Investigative Site Oxford OX3 7LJ United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field